Meeting

Promoting Health Equity in Cancer Care: An Innovation Showcase

May 10, 2022

Virtual | 1:00 p.m. - 3:00 p.m. EST

Session Overview

Now more than ever, organizations across the health care industry recognize that non-clinical factors, such as zip code, race, gender, ethnicity, and socioeconomic status, can impact cancer incidence and outcomes. To advance equity in cancer care, organizations across the country are implementing innovative strategies to identify and address these disparities.

Advisory Board is hosting a cross-industry virtual event, Promoting Health Equity in Cancer Care: An Innovation Showcase on Tuesday, May 10th, from 1 - 3 p.m. The event, sponsored by Pfizer, will highlight some of the most thoughtful and impactful strategies to address disparities in cancer prevention, screening, and treatment implemented across the health care industry (hospitals and health systems, health plans, life sciences companies, technology companies, and more).

Our innovation showcase finalists:

American Cancer Society
Castell (an Intermountain Company)
Jasper Health
Moffitt Cancer Center
Montefiore Medical Center
Native American Cancer Initiatives, Inc.
Penn State College of Medicine
University of Illinois at Chicago

Organizations are welcome to use the link below to register to attend the showcase as audience members.

  Not a member? You can still join us. Register here

Sponsored by
Pfizer logo

This workshop is sponsored by Pfizer for educational purposes only. The content, views, and opinions contained within the workshop are copyrighted by Advisory Board and all rights are reserved.

 
FAQs
  • Who is eligible to submit an initiative?
  • What innovations are eligible?
  • What are the benefits of participation?
  • Who should attend?
  • Is this event sponsored?
  • Who can I contact with questions?
 

About the sponsor

At Pfizer Oncology, we are committed to advancing medicines wherever we believe we can make a meaningful difference in the lives of people living with cancer. Today, we have an industry-leading portfolio of 24 approved innovative cancer medicines and biosimilars across more than 30 indications, including breast, genitourinary, colorectal, blood and lung cancers, as well as melanoma.

Learn more about Pfizer

This workshop is sponsored by Pfizer for educational purposes only. The content, views, and opinions contained within the workshop are copyrighted by Advisory Board and all rights are reserved. Advisory Board experts wrote the content, conducting the underlying research independently and objectively. Advisory Board does not endorse any company, organization, product or brand mentioned herein.

View Advisory Board's editorial guidelines

X
Cookies help us improve your website experience. By using our website, you agree to our use of cookies.